Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
2
×
life sciences
acute myeloid leukemia
alx oncology
autoimmune diseases
berkeley lights
bioinnovation capital
biolabs
biotech ipos
boston
boston top stories
cancer drugs
cancer immunotherapy
cd47
chemotherapy
chronic kidney disease
clinical trials
daraprim
deals
deerfield healthcare technology acquisitions
deerfield management company
drug pricing
drugs
epipen
epipens
europe blog main
europe top stories
exome
fda
gene therapy
generic drugs
immunotherapy
insulin
investing
johannes fruehauf
kidney disease
labcentral
life science
martin shkreli
What
biotech
2
×
industry
2
×
life
arrival
companies
days
driving
drug
good
hasn’t
healthcare
history
improved
innovation
innovations
investment
ipo
ipos
long
market
medical
momentum
new
outcomes
pricing
proud
public
raised
research
science
sciences
slowed
street
summer’s
wall
week
welcomed
wide
Language
unset
Current search:
biotech
×
industry
×
" boston blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good